Updated on 3 January 2014
Firms that appear on the list once will be banned from selling within the region where they were implicated for two years
Singapore: China has decided to introduce a healthcare corruption ‘blacklist' this 2014 to nab drugmakers and medical device manufacturers found to have paid bribes.
As part of its extended crackdown on corruption in the healthcare sector, this move from China will have healthcare departments compiling lists of offending manufacturers, agents and individuals. The country's National Health and Family Planning Commission has said that this list will then be published online and will come into effect from March.
The commission stated that firms that appear on the list once will be banned from selling within the region where they were implicated for two years. Those appearing on the list twice in five years will be banned nationally, also for two years.
It added, the blacklists will include those found guilty of relatively minor bribery but who may not have been punished by China's courts, as well as those who have received administrative punishments from sector and financial watchdogs.
The blacklists will display the name of the manufacturer or agent, its business address and legal representative, as well as details of the alleged crime, the commission said.